Perinatal Outcomes of Placental Chorangioma: A Single Center Study

To determine the incidence of placental chorangioma and evaluate its associated perinatal complications and mortality.

A retrospective observational study was conducted at Fernandez Hospitals, Hyderabad, India, from March 2011 to March 2025. All singleton pregnancies with structurally normal fetuses diagnosed antenatally with placental chorangioma and delivered at our center, with postnatal confirmation by histopathological examination (HPE), were included in the study. The diagnosis was made using B-mode ultrasound examination and color Doppler flow imaging, demonstrating a well-circumscribed hypo or hyperechoic placental mass with a clearly identifiable vascular supply. Demographic details, prenatal sonographic findings, perinatal and neonatal outcomes were collected from electronic medical records.

A total of 20 cases were included, with an incidence of 9.8 per 100 000 pregnancies. Large chorangiomas (≥ 4 cm) accounted for 90% of cases, while small chorangiomas (< 4 cm) accounted for 10%. The mean gestational age at diagnosis was 27.65 ± 5.27 weeks. Sixteen cases (80%) were managed conservatively, while four cases (20%) required prenatal intervention. Polyhydramnios was observed in 12 (60%) fetuses and cardiomegaly in 5 (25%). Fifteen fetuses (75%) were appropriate for gestational age, four (20%) had fetal growth restriction, and one (5%) was large for gestational age secondary to hydrops. Eleven pregnancies (55%) resulted in preterm birth. Nine neonates (45%) required admission to the neonatal intensive care unit (NICU), and eight (40%) experienced adverse neonatal outcomes. No neonatal deaths occurred despite the predominance of large chorangiomas in the study population.

Serial ultrasound surveillance with meticulous fetal assessment enabled early identification of asymptomatic chorangiomas and timely intervention when required, resulting in favorable perinatal outcomes.